Indegene Ltd (NSE:INDGN)

Full Year 2025 Indegene Ltd Earnings Call Transcript

Apr 28, 2025 / 03:30 AM GMT

Release Date Price: ₹558.1 (-2.34%)

Transcript

Key Points

Positve

Indegene Ltd (NSE:INDGN) reported a 9.6% year-on-year revenue growth for the full year, driven by growth in existing customers and new account additions.
The company launched its GAI platform, Cortex, which helps contextualize AI for the life sciences industry, leveraging 26 years of operational experience.
Indegene Ltd (NSE:INDGN) has maintained a strong cash position with INR11,664 million in cash and cash equivalents, providing ample liquidity for expansion.
The company has seen growth in its USD1 million clients, increasing from 35 to 41 year-on-year, indicating deeper engagements with mid-size pharma companies.
Indegene Ltd (NSE:INDGN) announced a 100% dividend, reflecting its commitment to returning value to shareholders even as a young publicly listed company.

Negative

The company experienced a slowdown in decision-making processes due to macroeconomic uncertainties, impacting larger transformational initiatives.
There was a slight decrease in the total number of active clients from 75 to 73, attributed to the completion of some one-time revenue projects.
Indegene Ltd (NSE:INDGN) faced headwinds with two of its top five customers, impacting revenue growth in the enterprise commercial segment.
The company reported a drop in EBITA margins by 90 basis points year-on-year, mainly due to a higher on-site employee mix and increased non-employee expenses related to technology.
The reduction in FDA staff and potential delays in submission reviews pose challenges, although Indegene Ltd (NSE:INDGN) sees this as a medium-term opportunity.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

INEG.NS - Indegene Ltd
Full Year 2025 Indegene Ltd Earnings Call
Apr 29, 2025 / 03:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, good day and welcome to the Q4 NFY25 earnings conference call of Indigen Limited.

As a reminder, all participant lines will be in the listener lead mode, and there will be an opportunity for you to ask questions after the presentation concludes.

Should you need assistance during the conference call, please signal an operator by pressing the star, then 0 on the touchstone phone.

I now have a conference over to Mr. Abhishek Agarwal.

Thank you and over to you, sir.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, moderator

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.